Differentiation of pluripotent stem cells into endothelial cells

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Purpose of review Methods to isolate endothelial cells from murine and human pluripotent stem cells continue to evolve and increasingly diverse endothelial cell populations have been generated. This review provides an update of key articles published within the past year that report on some of those advances. Recent findings Cooperative interactions among microRNA (miRNA), transcription factors and some downstream interacting proteins have been reported to enhance endothelial specification from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). Endothelial cell differentiation can also be modulated by various growth factor additions, Notch pathway activation or inhibition, and modulation of the microenvironment of the differentiating ESC and iPSC. Functionality of the derived endothelium has been demonstrated by a variety of in-vitro and in-vivo assays. Finally, two recent reports have identified endothelial progenitor populations with robust proliferative potential. Summary Progress in differentiating endothelial cells from ESC and iPSC has been made. The recent report of formation of endothelial colony forming cells from human ESC and iPSC provides a protocol that can generate clinically relevant numbers of cells for human cell therapy.

Original languageEnglish (US)
Pages (from-to)252-257
Number of pages6
JournalCurrent Opinion in Hematology
Volume22
Issue number3
DOIs
StatePublished - May 27 2015

Fingerprint

Induced Pluripotent Stem Cells
Pluripotent Stem Cells
Embryonic Stem Cells
Endothelial Cells
Cell- and Tissue-Based Therapy
MicroRNAs
Population
Endothelium
Cell Differentiation
Intercellular Signaling Peptides and Proteins
Transcription Factors
Cell Count
Proteins

Keywords

  • embryonic stem cells
  • endothelial cells
  • endothelial colony forming cells
  • induced pluripotent stem cells

ASJC Scopus subject areas

  • Hematology

Cite this

Differentiation of pluripotent stem cells into endothelial cells. / Yoder, Mervin.

In: Current Opinion in Hematology, Vol. 22, No. 3, 27.05.2015, p. 252-257.

Research output: Contribution to journalArticle

@article{528c3bdb5be7494daeb47fa2938c63e4,
title = "Differentiation of pluripotent stem cells into endothelial cells",
abstract = "Purpose of review Methods to isolate endothelial cells from murine and human pluripotent stem cells continue to evolve and increasingly diverse endothelial cell populations have been generated. This review provides an update of key articles published within the past year that report on some of those advances. Recent findings Cooperative interactions among microRNA (miRNA), transcription factors and some downstream interacting proteins have been reported to enhance endothelial specification from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). Endothelial cell differentiation can also be modulated by various growth factor additions, Notch pathway activation or inhibition, and modulation of the microenvironment of the differentiating ESC and iPSC. Functionality of the derived endothelium has been demonstrated by a variety of in-vitro and in-vivo assays. Finally, two recent reports have identified endothelial progenitor populations with robust proliferative potential. Summary Progress in differentiating endothelial cells from ESC and iPSC has been made. The recent report of formation of endothelial colony forming cells from human ESC and iPSC provides a protocol that can generate clinically relevant numbers of cells for human cell therapy.",
keywords = "embryonic stem cells, endothelial cells, endothelial colony forming cells, induced pluripotent stem cells",
author = "Mervin Yoder",
year = "2015",
month = "5",
day = "27",
doi = "10.1097/MOH.0000000000000140",
language = "English (US)",
volume = "22",
pages = "252--257",
journal = "Current Opinion in Hematology",
issn = "1065-6251",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Differentiation of pluripotent stem cells into endothelial cells

AU - Yoder, Mervin

PY - 2015/5/27

Y1 - 2015/5/27

N2 - Purpose of review Methods to isolate endothelial cells from murine and human pluripotent stem cells continue to evolve and increasingly diverse endothelial cell populations have been generated. This review provides an update of key articles published within the past year that report on some of those advances. Recent findings Cooperative interactions among microRNA (miRNA), transcription factors and some downstream interacting proteins have been reported to enhance endothelial specification from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). Endothelial cell differentiation can also be modulated by various growth factor additions, Notch pathway activation or inhibition, and modulation of the microenvironment of the differentiating ESC and iPSC. Functionality of the derived endothelium has been demonstrated by a variety of in-vitro and in-vivo assays. Finally, two recent reports have identified endothelial progenitor populations with robust proliferative potential. Summary Progress in differentiating endothelial cells from ESC and iPSC has been made. The recent report of formation of endothelial colony forming cells from human ESC and iPSC provides a protocol that can generate clinically relevant numbers of cells for human cell therapy.

AB - Purpose of review Methods to isolate endothelial cells from murine and human pluripotent stem cells continue to evolve and increasingly diverse endothelial cell populations have been generated. This review provides an update of key articles published within the past year that report on some of those advances. Recent findings Cooperative interactions among microRNA (miRNA), transcription factors and some downstream interacting proteins have been reported to enhance endothelial specification from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). Endothelial cell differentiation can also be modulated by various growth factor additions, Notch pathway activation or inhibition, and modulation of the microenvironment of the differentiating ESC and iPSC. Functionality of the derived endothelium has been demonstrated by a variety of in-vitro and in-vivo assays. Finally, two recent reports have identified endothelial progenitor populations with robust proliferative potential. Summary Progress in differentiating endothelial cells from ESC and iPSC has been made. The recent report of formation of endothelial colony forming cells from human ESC and iPSC provides a protocol that can generate clinically relevant numbers of cells for human cell therapy.

KW - embryonic stem cells

KW - endothelial cells

KW - endothelial colony forming cells

KW - induced pluripotent stem cells

UR - http://www.scopus.com/inward/record.url?scp=84928478759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928478759&partnerID=8YFLogxK

U2 - 10.1097/MOH.0000000000000140

DO - 10.1097/MOH.0000000000000140

M3 - Article

C2 - 25767955

AN - SCOPUS:84928478759

VL - 22

SP - 252

EP - 257

JO - Current Opinion in Hematology

JF - Current Opinion in Hematology

SN - 1065-6251

IS - 3

ER -